594 related articles for article (PubMed ID: 29580128)
1. Breast cancer lung metastasis: Molecular biology and therapeutic implications.
Jin L; Han B; Siegel E; Cui Y; Giuliano A; Cui X
Cancer Biol Ther; 2018; 19(10):858-868. PubMed ID: 29580128
[TBL] [Abstract][Full Text] [Related]
2. Organotropism of breast cancer metastasis.
Lu X; Kang Y
J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):153-62. PubMed ID: 17566854
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
4. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.
Medeiros B; Allan AL
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071959
[TBL] [Abstract][Full Text] [Related]
6. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
7. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
8. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
10. Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.
Yousefi M; Nosrati R; Salmaninejad A; Dehghani S; Shahryari A; Saberi A
Cell Oncol (Dordr); 2018 Apr; 41(2):123-140. PubMed ID: 29568985
[TBL] [Abstract][Full Text] [Related]
11. Confounding effects in "a six-gene signature predicting breast cancer lung metastasis": reply.
Driouch K; Bonin F; Sin S; Clairac G; Lidereau R
Cancer Res; 2009 Dec; 69(24):9507-11. PubMed ID: 19934332
[TBL] [Abstract][Full Text] [Related]
12. Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone.
Guiu M; Arenas EJ; Gawrzak S; Pavlovic M; Gomis RR
Methods Mol Biol; 2015; 1293():221-9. PubMed ID: 26040691
[TBL] [Abstract][Full Text] [Related]
13. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
14. p63 at the Crossroads between Stemness and Metastasis in Breast Cancer.
Gatti V; Bongiorno-Borbone L; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159154
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
16. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
18. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
Allan AL; Vantyghem SA; Tuck AB; Chambers AF
Breast Dis; 2006-2007; 26():87-98. PubMed ID: 17473368
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract][Full Text] [Related]
20. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
Liang Y; Zhang H; Song X; Yang Q
Semin Cancer Biol; 2020 Feb; 60():14-27. PubMed ID: 31421262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
